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The phytochemical investigation of  Gymnocarpos decander aerial parts extract afforded two new
saponins,  3-O-β-D-glucuronopyranosyl-2β,3β,16α,23-tetrahydroxyolean-12-en-28-O-β-D-
apiofuranosyl-(1→3)-β-D-xylopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→2)-α-L-
arabinopyranosyl  ester  (1),  3-O-β-D-glucuronopyranosyl-2β,3β,16α-trihydroxyolean-12-en-28-O-
α-L-rhamnopyranosyl-(1→3)-β-D-xylopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→2)-α-L-
arabinopyranosyl ester (2) and three new flavonol glycosides, isorhamnetin 3-O-2''''-O-acetyl−β-D-
xylopyranosyl-(1→6)-[β-D-apiofuranosyl-(1→2)]-β-D-glucopyranoside (3),  isorhamnetin  3-O-2'''-
O-acetyl−β-D-xylopyranosyl-(1→6)-β-D-glucopyranoside (4), and quercetin 3-O-2'''-O-acetyl−β-D-
xylopyranosyl-(1→6)-β-D-glucopyranoside (5),  together  with  three  known  compounds. Their
structures were determined by spectroscopic methods including 1D and 2D NMR analysis and high
resolution  mass  spectrometry.  The  new  isolates  were  investigated  for  their  potential  cytotoxic
activity on three cancer cell lines. Compounds 1 and 2 showed a moderate antiproliferative activity.
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Introduction 
Gymnocarpos  is a genus of Caryophyllaceae family including  woody and undershrub plants with
succulent and  mucronate leaves,  native of the Canary Islands, North Africa, and Middle East  [1].
Gymnocarpos decander Forssk. is a 30-50 cm tall undershrub, widely grown in Algeria in rocks and
stony soils without sand. The species has locally an economic value since it is used as fuel wood
and feed for grazing [2, 3]. The whole plant or its aerial parts are used against helmintiasis [4] and
have some traditional uses, such as against kidney stones, psychosomatic diseases, and to break
down  evil  eye  and  bad  spirits  [5,  6].  Moreover,  the  potential  anti-malarial  efficacy  of  a
hydroalcoholic  extract  was  reported  [7].  The  composition  of  the  essential  oil  [8]  and  the
polyphenols  content,  the  antioxidant  and  the  antimicrobial  activities  of  the  aerial  parts  were
investigated [9]. On the contrary, no information is available on the chemical composition of polar
extracts. Thus, the present investigation was designed to carry out a phytochemical  study of  G.
decander aerial  parts  and  to  evaluate  the  cytotoxic  properties  of  the  new  isolated  chemical
constituents. 
Results and Discussion
The crude methanolic aerial parts extract of G. decander was partitioned between chloroform, ethyl
acetate, and n-butanol. A portion of the n-BuOH soluble portion was subjected to Sephadex LH-20
column  chromatography followed by RP-HPLC, to afford  two new triterpenoid saponins  (1-2),
three new flavonol glycosides (3-5) (Fig. 1), along with three known compounds.
Compound 1, obtained as white amorphous powder, was assigned the molecular formula C57H90O28
as  determined  by  its  negative  HRESIMS  data  (m/z 1221.5527  [M-H]-).  The  HRESIMS/MS
spectrum showed peaks at  m/z 1089.53 [M-H-132]-,  957.53 [M-H-132-132]-,  811.47 [M-H-132-
132-146]-,  679.36  [M-H-132-132-146-132]-,  503.33  [M-H-132-132-146-132-176]- due  to  the
subsequent  loss  of  two  pentoses,  one  deoxyhexose,  one  pentose,  and  one  uronic  acid  unit,
respectively. The peak at m/z 503.33 was attributed to the aglycon moiety. Analysis of 1H and 13C
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NMR data (Tables 1 and 2) suggested a triterpenoid saponin structure. The 1H NMR spectrum of 1
revealed the presence of six singlet methyl groups (δ 0.81, 0.90, 0.98, 1.00, 1.32, and 1.40), one
doublet methyl group at δ 1.30 (d, J = 6.5 Hz), signals of three hydroxymethines at δ 3.64 (d, J =
4.5 Hz), 4.36 (ddd,  J = 13.0, 9.2, 3.9 Hz), 4.52 (br s), one hydroxymethylene at  δ 3.25 and 3.66
(each, d,  J = 12.0 Hz), a resonance for an olefinic hydrogen at  δ 5.40 (t,  J = 3.5 Hz), and five
anomeric protons [δ 4.49 d (J = 7.8 Hz), 4.56 d (J = 7.5 Hz), 5.09 d (J = 1.8 Hz), 5.26 d (J = 3.0
Hz),  5.64  d  (J =  6.8  Hz)].  The  13C NMR spectrum  showed,  for  the  aglycon  moiety,  signals
attributable to a triterpene skeleton confirmed by HSQC experiment, leading to the identification of
the  aglycon  as  2β,3β,16α,23-tetrahydroxyolean-12-en-28-oic  acid  (polygalacic  acid)  [10].  The
structures of the sugar moieties were deduced by using 1D TOCSY and 2D NMR experiments,
which  indicated  the  presence  of  one  β-glucuronic  acid,  one  α-arabinose  in  a  predominant  4C1
conformation  (ara  JH-1/H-2 =  6.8  Hz),  one  α-rhamnose,  one  β-xylose  in  a  predominant  
4C1
conformation (xyl JH-1/H-2 = 7.5 Hz), and one β-apiose [11]. The assignments of proton and carbon
chemical  shifts  by  HSQC  experiment,  indicated  that  the  glucuronopyranosyl  acid  and  the
apiofuranosyl units were the terminal units. The configuration of the sugar units was assigned after
hydrolysis of  1 with 1 N HCl. The hydrolyzate was trimethylsilylated, and GC retention times of
each  sugar  were  compared  with those of  authentic  samples  prepared  in  the same manner.  The
HMBC correlations between H-1ara-C-28, H-1rha-C-2ara, H-1xyl-C-4rha, H-1api-C-3xyl, and H-1glc-A-C-3
allowed the identification of the sugar sequence. Therefore, compound 1 was identified as 3-O-β-D-
glucuronopyranosyl-2β,3β,16α,23-tetrahydroxyolean-12-en-28-O-β-D-apiofuranosyl-(1→3)-β-D-
xylopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→2)-α-L-arabinopyranosyl ester.
Compound 2 was purified as a white amorphous powder. Its molecular formula was determined to
be C58H92O27 from the pseudo molecular ion [M+Na]
+ at m/z 1243.5592 in the HRESIMS spectrum
(positive mode). Analysis of NMR data (Tables 1 and 2) of compound 2 led to establish again the
presence of a triterpenoid saponin structure with five sugar units. Comparison of NMR spectra with
those of 1 revealed 2 to differ from 1 both in the aglycon moiety and in the sugar chain at C-28,
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while the  β-glucuronopyranosyl  moiety at  C-3 was identical.  NMR data of  the aglycon moiety
showed the presence of seven methyl singlets, at δ 0.81, 0.90, 0.98, 1.10, 1.11, 1.27, and 1.40, three
hydroxymethines at  δ 3.89 (d,  J = 4.5 Hz), 4.23 (ddd,  J = 13.0, 9.2, 3.8 Hz), 4.51 (br s), and a
resonance for an olefinic hydrogen at δ 5.40 (t, J = 3.5 Hz), allowing to characterize the structure of
the aglycon as 2β,3β,16α-trihydroxyolean-12-en-28-oic acid (asterogenic acid) [12]. The proton-
coupling network within each sugar residue was traced out using a combination of 1D TOCSY,
DQF-COSY, HSQC, and HMBC experiments.  These results established that  the tetrasaccharide
chain at C-28 contains a terminal α-rhamnopyranose in 2 instead of a β-apiofuranose in 1. The D or
L configuration of sugar moieties were determined by hydrolysis of 2, trimethylsilylation, and GC
analysis,  as  reported  for  1.  Thus,  the  structure  of  3-O-β-D-glucuronopyranosyl-2β,3β,16α-
trihydroxyolean-12-en-28-O-α-L-rhamnopyranosyl-(1→3)-β-D-xylopyranosyl-(1→4)-α-L-
rhamnopyranosyl-(1→2)-α-L-arabinopyranosyl ester was assigned to compound 2.
Compound 3, a yellow amorphous solid, showed a quasi molecular ion peak at  m/z 807.1951 for
[M+Na]+ in  the  HRESIMS, allowing the  assignment  of  molecular  formula  C34H40O21.  The  UV
spectrum of 3 showed two absorption maxima at 251 and 354 nm, indicating its flavonol skeleton.
The  1H and  13C NMR spectra  (Table 3) showed a typical  pattern of a  flavonol acyl glycoside.
Compound 3 aglycon was deduced to be isorhamnetin [13] from the presence of two meta-coupled
protons for ring A (δ 6.22 and 6.49, d, J = 1.8 Hz) and an ABX system signals for ring B (δ 6.95 d,
J = 8.5 Hz, 7.74 dd, J = 8.5, 2.0 Hz, and 8.30 d,  J = 2.0), together with one methoxy signal at  δ
4.03. Three anomeric protons arising from the sugar moieties appeared at δ 4.24 (J = 7.5 Hz), 5.46
(J = 2.0 Hz), and 5.51 (J = 7.5 Hz) and correlated respectively with signals at δ 102.3, 110.4, and
101.6 in the HSQC spectrum. Moreover, a signal of an acetyl group (δH 1.71,  δC 20.0) was also
evident. DQF-COSY and 1D TOCSY experiments, together with HSQC cross peaks interpretation
led to identify the sugars as one β-glucopyranosyl, one β-apiofuranosyl, and one β-xylopyranosyl
unit.  The  sugar  moiety  configuration  was  established  as  reported  for  1 and  2.  Unambiguous
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determination  of  the  substitution  sites  was  obtained  from  the  HMBC  experiment  showing
correlations between H-1glc—C-3, H-1api—C-2glc, H-1xyl—C-6glc,  H-2xyl—OCOCH3. In the light of
these data, the structure of 3 was elucidated as isorhamnetin 3-O-2''''-O-acetyl−β-D-xylopyranosyl-
(1→6)-[β-D-apiofuranosyl-(1→2)]-β-D-glucopyranoside.
The HRESIMS of compound 4, a yellow amorphous powder, displayed a quasi molecular ion peak
at  m/z 675.1529 [M+Na]+ corresponding to C29H32O17 molecular formula. Comparison of the MS
and NMR data of 4 (Table 3) with those of 3 showed the absence of the terminal β-apiofuranosyl
unit  in  4.  Thus,  compound  4 was  established  to  be  isorhamnetin  3-O-2'''-O-acetyl−β-D-
xylopyranosyl-(1→6)-β-D-glucopyranoside.
The  HRESIMS  of  compound  5,  obtained  as  a  yellow  amorphous  powder,  displayed  a  quasi
molecular  ion peak  at  m/z 661.1360,  14 uma less  than that  of  4.  Its  NMR profile  was  almost
identical to that of 4 (Table 3), being the NMR signals of flavonol B-ring the point of difference.
The absence of the methoxy signal in 5 led to identify quercetin as its aglycon [13]. On the basis of
this evidence, the structure of compound 5  was established to be quercetin 3-O-2'''-O-acetyl−β-D-
xylopyranosyl-(1→6)-β-D-glucopyranoside.
Roseoside [14],  quercetin 3-O-β-D-xylopyranosyl-(1→6)-β-D-glucopyranoside [15], and quercetin
3-O-β-D-glucopyranoside [13]  were  also identified  by comparison with published spectroscopic
data.
The antiproliferative activity of new compounds  1-5 was evaluated in HeLa,  MCF7 and Jurkat
cancer cell lines. Cell viability was evaluated at 48 h treatment by MTT assay. Only compounds 1
and  2 inhibited the growth of all cell lines in a dose- and time-dependent manner.  Half maximal
inhibitory concentration (IC50) values, obtained from dose-response curves, are shown in Table 4.
Jurkat cells were slightly more susceptible than HeLa and MCF7 cells.
Furthermore, the cytotoxic potential of compounds 1 and 2 was evaluated in PBMC from healthy
donors, chosen as the normal counterpart of leukemia-derived Jurkat cell line. Compounds 1 and 2
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did not causes any significant reduction of the number of freshly isolated non-proliferating PBMC,
at least in the range of doses cytotoxic in leukemia cells.
Materials and Methods
General experimental procedures
Optical rotations were measured on a Autopol IV Automatic polarimeter (Rudolph) equipped with a
sodium lamp (589 nm) and a 1 dm microcell.  UV spectra  were  recorded on an Evolution 201
(Thermo Scientific) spectrophotometer. NMR experiments were performed on a Bruker DRX-600
spectrometer  (Bruker BioSpin GmBH) equipped with a Bruker 5 mm TCI CryoProbe at 300 K.
Chemical shifts were expressed in δ (parts per million) referred to the solvent peaks δH 3.34 and δC
49.0 for CD3OD. The NMR data were processed on a Silicon Graphic Indigo2 Workstation using
XWINNMR software. Standard pulse  sequences  and phase cycling were used  for  DQF-COSY,
TOCSY, HSQC, and HMBC experiments. HRESIMS were acquired in positive and negative ion
mode  on  a  Q-TOF  premier  spectrometer  equipped  with  a  nanospray  source.  Column
chromatography  was  performed  over  Sephadex  LH-20  (Pharmacia). HPLC  separations  were
conducted on a Waters 590 series pumping system equipped with a Waters R401 refractive index
detector, a  Luna C8 10 µ  (250 x 10 mm)  column (Phenomenex), and a U6K injector. TLC were
carried out on precoated Kieselgel 60 F254 plates (Merck); compounds were detected by Ce(SO4)2/
H2SO4 (Sigma-Aldrich) solution. GC analysis was performed using a Dani GC 1000 instrument on
a L-CP-Chirasil-Val column (0.32 mm × 25 m) working with the following temperature program:
100 °C for 1 min, ramp of 5 °C/min up to 180 °C; injector and detector temperature 200 °C; carrier
gas N2 (2 mL/min); detector dual FID; split ratio 1:30; injection 5 µL.
Plant material
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The aerial parts of  G. decander (Caryophyllaceae) were collected during the flowering period, in
April 2013, in the region of Bechar, southwest of Algeria. The plant was identifed by Dr. Mohamed
Benabdelhakem head of the Bechar National Agency of Natural Resources Preservation. A voucher
specimen (n.  GD149/13/VARENBIOMOL) was deposited in the Herbarium of the Department of
Chemistry, University of Mentouri, Algeria.
Extraction and isolation
The aerial parts of G. decander (1.7 Kg) were powdered and successively extracted by exhaustive
maceration in methanolic solution (80%, 10 L), filtered and the solvent was removed under vacuum
at 40 °C in a rotary evaporator, obtaining respectively 97.8 g of dried extract. All the extract was
partitioned with chloroform (0.22 L), ethyl acetate (0.22 L), and  n-butanol (n-BuOH) (0.22 L), 3
times each, to yield 3.66, 1.94, and 10.40 g of the respective residues. A portion (2.5 g) of the n-
BuOH-soluble fraction was separated by Sephadex LH-20 with MeOH as eluent (flow rate 1.1 mL/
min). Fractions of 10 mL were collected, analyzed by TLC on silica 60 F254 gel-coated glass sheets
with n-BuOH-AcOH-H2O (60:15:25 v/v/v) and grouped to obtain five fractions (A–E). Fraction A
(452.1 mg, 200 mL) was purified by RP-HPLC using MeOH–H2O (1:1) to give compounds 1 (4.4
mg, tR 21 min) and 2 (4.0 mg, tR 27 min). Fraction B (126 mg, 100 mL), C (129.7 mg, 110 mL), and
D (219.1  mg,  150 mL)  were  separately  purified  by RP-HPLC using MeOH-H2O (2:3)  to  give
roseoside (2.4 mg, tR 15 min) from fraction B, compound 3 (10.0 mg, tR 12 min) from fraction C,
and compounds 4 (7.0 mg, tR 28 min) and 5 (15.9 mg, tR 19 min) from fraction D. Fraction E (70.0
mg, 300 mL) was  purified by RP-HPLC using MeOH-H2O (35:65) to give quercetin  3-O-β-D-
xylopyranosyl-(1→6)-β-D-glucopyranoside  (2.2  mg,  tR 30  min)  and  quercetin  3-O-β-D-
glucopyranoside (2.0 mg, tR 35 min). All the compounds met the criteria of ≥95% purity, as inferred
by HPLC and NMR analyses.
Compound 1: white amorphous powder; -33.8 (c 0.13, MeOH); 1H and 13C NMR data for the
aglycon moiety, see Table 1; 1H and 13C NMR data for the sugar moiety, see Table 2; HRESIMS:
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m/z 1221.5527 [M-H]- (calcd. for  C57H89O28,  m/z 1221.5540); MS/MS m/z 1089.53 [(M-132)-H]
-,
957.53  [(M-132-132)-H]-,  811.47  [(M-132-132-146)-H]-,  679.36  [(M-132-132-146-132)-H]-,
503.33 [(M-132-132-146-132-176)-H]-.
Compound 2: white amorphous powder; -55.0 (c 0.08, MeOH); 1H and 13C NMR data for the
aglycon moiety, see Table 1; 1H and 13C NMR data for the sugar moiety, see Table 2; HRESIMS:
m/z 1243.5592 [M+Na]+ (calcd. for C58H92NaO27, m/z 1243.5724).
Compound 3  -48.6 (c 0.25, MeOH); UV (MeOH) λmax (log ε): 251
(3.90), 354 (2.25); 1H and 13C NMR data, see Table 3; HRESIMS: m/z 807.1951 [M+Na]+ (calcd.
for C34H40NaO21, 807.1960).
Compound 4  -27.1 (c 0.13, MeOH); UV (MeOH) λmax (log ε): 253
(2.80), 356 (1.29); 1H and 13C NMR data, see Table 3; HRESIMS: m/z 675.1529 [M+Na]+ (calcd.
for C29H32NaO17, 675.1537).
Compound 5: yellow amorphous powder;  + 4.3 (c 1.01, MeOH); UV (MeOH) λmax (log ε): 257
(2.40), 362 (1.48); 1H and 13C NMR data, see Table 3; HRESIMS: m/z 661.1360 [M+Na]+ (calcd.
for C28H30NaO17, 661.1381).
Acid hydrolysis of compounds 1-5
A solution of each compound (2.0 mg) in 1 N HCl (1 mL) was stirred at 80 °C in a stoppered
reaction vial for 4 h. After cooling, the solution was evaporated under a stream of N2. The residue
was dissolved in 1-(trimethylsilyl)imidazole and pyridine (0.2 mL), and the solution was stirred at
60 °C for 5 min. After drying the solution, the residue was partitioned between H2O and CHCl3. The
CHCl3 layer  was  analyzed  by  GC  using  a  L-CP-Chirasil-Val  column  (0.32  mm  x  25  m).
Temperatures of both the injector and detector was 200 °C. A temperature gradient system was used
for the oven, starting at 100 °C for 1 min and increasing up to 180 °C at a rate of 5 °C/min. Peaks of
the  hydrolysate  were  detected  by  comparison  with  retention  times  of  authentic  samples  of  D-
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glucuronic acid, L-arabinose, L-rhamnose, D-xylose, D-apiose, and D-glucose (Sigma Aldrich) after
treatment with 1-(trimethylsilyl)imidazole in pyridine.
Cytotoxicity assay
Cells and treatment
Jurkat cells  (T-cell leukemia), obtained from Cell Bank in GMP-IST, were maintained in RPMI
1640 medium, 2 mML-glutamine and antibiotics at 37 °C in a humidified atmosphere of 5% CO2.
HeLa (cervical carcinoma) and MCF7 (breast carcinoma) cells were obtained from American Type
Culture Collection (ATCC). Cells were maintained in DMEM, supplemented with 10% FBS, 100
mg/L streptomycin and penicillin 100 IU/mL at 37°C in a humidified atmosphere of 5% CO2. To
ensure  logarithmic  growth,  cells  were  subcultured  every  two  days.  Human  peripheral  blood
mononuclear cells (PBMC) were isolated from buffy coats of healthy donors (kindly provided by
the Blood Center of the Hospital of Battipaglia, Salerno, Italy) by using a standard Ficoll–Hypaque
gradient. Freshly isolated PBMC contained 90.6 ± 1.2% live cells as assessed by the manual Trypan
blue exclusion method. Stock solutions (50 mM) of compounds 1-5 in DMSO were stored in the
dark at 4 °C. Appropriate dilutions were prepared in culture medium immediately prior to use. In all
experiments, the final concentration of DMSO did not exceed 0.15% (v/v). 
Cell viability
Cells were seeded in 96-well plates and incubated for the established times in the absence (vehicle
only) and in the presence of different concentrations of compounds. Jurkat cells were seeded at a
cell density of 2×104/well; HeLa and MCF7 were seeded at a density of 1×104/well the day before
treatment. The number of viable cells was quantified by MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide]) assay. Absorption at 550 nm for each well was assessed using a
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microplate reader (LabSystems).  In some experiments cell viability was also checked by Trypan
Blue exclusion assay  using a Bürker  counting chamber. Half  maximal  inhibitory  concentration
(IC50)  values  were  calculated  from  cell  viability  dose–response  curves  and  defined  as  the
concentration resulting in 50% inhibition in cell survival as compared to controls [16]. Etoposide
was used as a positive control. Each experimental condition was tested once in quadruplicate. IC50
values were performed with GraphPad software.
Supporting information
HRESIMS and NMR spectra of compounds  1-5 and data for the IC50 determination of cytotoxic
activity are available as Supporting Information.
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Figure legend:
Fig. 1 Chemical structures of compounds 1-5 isolated from G. decander aerial parts
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Table 1 1H and 13C-NMR data for aglycons of compounds 1-2 (CD3OD, 600 MHz, J in Hz).
position 1 2
δH δC δH δC
1a 2.10 m 44.6 2.06 m 45.0
1b 1.20 dd (13.5, 2.8) 1.21 dd (13.5, 2.6)
2 4.36 ddd (13.0, 9.2, 3.9) 70.8 4.23 ddd (13.0, 9.2, 3.8) 70.8
3 3.64 d (4.5) 83.8 3.89 d (4.5) 91.0
4 48.9 39.9
5 1.34a 48.5 0.89a 57.6
6a 1.54a 18.8 1.59a 19.6
6b 1.49a 1.51a
7a 1.66 m 33.6 1.66 m 34.3
7b 1.38 m 1.38 m
8 43.0 43.5
9 1.65 dd (11.0, 5.3) 48.3 1.59a 48.8
10 37.8 39.0
11a 2.01a 24.6 2.00a 24.9
11b 1.98a 1.98a
12 5.40 t (3.5) 123.9 5.40 t (3.5) 124.0
13 144.7 145.3
14 40.8 41.9
15a 1.93a 36.4 1.93a 36.5
15b 1.78a 1.78a
16 4.52 br s 74.6 4.51 br s 74.5
17 47.0 47.2
18 3.09 dd (13.5, 2.6) 42.0 3.08 dd (14.0, 3.2) 42.0
19a 2.30 t (13.2) 47.6 2.30 t (13.2) 47.0
19b 1.07a 1.06a
20 31.6 31.7
21a 1.41a 36.5 1.41a 35.7
21b 1.16a 1.15a
22a 1.94a 32.0 1.92a 32.0
22b 1.80a 1.78a
23a 3.66 d (12.0) 65.5 1.11 s 30.0
23b 3.25 d (12.0)
24 0.98 s 14.0 1.10 s 18.9
25 1.32 s 18.0 1.27 s 18.9
26 0.81 s 18.0 0.81 br s 18.3
27 1.40 s 27.0 1.40 s 27.0
28 177.0 178.2
29 0.90 s 33.0 0.90 s 33.9
30 1.00 s 25.3 0.98 s 26.0
Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments.
a Overlapped signal.
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Table 2 1H and 13C-NMR data for sugar moieties of compounds 1-2 (CD3OD, 600 MHz, J in Hz).
position 1 2
δH δC δH δC
GlcAa-1 4.49 d (7.8) 104.9 4.41 d (7.8) 102.6
2 3.35 dd (9.0, 7.8) 75.2 3.35 dd (9.5, 7.8) 75.7
3 3.40 t (9.0) 78.0 3.48 t (9.5) 78.0
4 3.44 t (9.0) 73.7 3.49 t (9.5) 71.8
5 3.68 d (9.0) 76.0 3.44 d (9.0) 76.0
6 172.0 172.0
Arab-1 5.64 d (6.8) 94.1 5.64 d (7.0) 94.4
2 3.82 dd (9.0, 6.8) 75.5 3.80 dd (9.0, 7.0) 75.9
3 3.88 dd (9.0, 2.0) 72.2 3.86 dd (9.0, 3.0) 71.9
4 3.84 m 67.0 3.85 m 67.0
5a 3.93 dd (12.0, 2.0) 64.0 3.91 dd (12.0, 2.5) 63.8
5b 3.52 dd (12.0, 4.0) 3.51 dd (12.0, 4.0)
Rhac-1 5.09 d (1.8) 101.4 5.04 d (1.5) 102.1
2 3.86 dd (3.0, 1.8) 72.0 3.89 dd (3.0, 1.5) 71.0
3 3.89 dd (9.0, 3.0) 71.5 3.86 dd (9.0, 3.0) 72.0
4 3.59 t (9.0) 83.6 3.57 t (9.0) 83.2
5 3.71 m 69.0 3.70 m 69.0
6 1.30 d (6.5) 18.0 1.31 d (6.5) 18.5
Xyld-1 4.56 d (7.5) 106.7 4.55 d (7.5) 107.0
2 3.40 dd (9.5, 7.5) 75.5 3.40 dd (9.0, 7.5) 74.6
3 3.41 t (9.5) 86.0 3.46 t (9.0) 84.5
4 3.55 m 69.9 3.53 m 70.4
5a 3.91 dd (11.0, 3.0) 66.8 3.89 dd (10.5, 2.5) 66.8
5b 3.23 dd (11.0, 4.5) 3.22 dd (10.5, 5.0)
Apie-1 5.26 d (3.0) 111.3
2 4.01 br s 77.9
3 80.8
4a 4.16 d (10.0) 74.8
4b 3.81 d (10.0)
5 3.61 br s 65.3
Rha-1 5.16 d (1.8) 102.8
2 3.96 dd (3.0, 1.8) 72.0
3 3.73 dd (9.5, 3.0) 71.8
4 3.44 t (9.5) 73.8
5 4.01 m 70.5
6 1.27 d (6.0) 18.0
Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments.
a  Glc-A  =  β-D-glucuronopyranosic  acid,  b  =  Ara α-L-arabinopyranose,  c  = Rha  α-L-
rhamnopyranose, d  = Xyl  β-D-xylopyranose, e  =  Api β-D .-apiofuranose
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Table 3 1H and 13C-NMR data of compounds 3-5 (CD3OD, 600 MHz, J in Hz).
position 3 4 5
δH δC δH δC δH δC
2 160.0 160.0 160.0
3 136.1 136.0 136.2
4 179.4 179.4 179.3
5 163.4 162.9 163.0
6 6.22 d (1.8) 99.6 6.23 d (1.8) 99.8 6.25 d (1.8) 99.0
7 167.2 167.6 165.0
8 6.49 d (1.8) 94.7 6.46 d (1.8) 95.5 6.43 d (1.8) 94.6
9 158.6 158.4 159.9
10 103.7 104.0 104.0
1' 124.0 124.2 123.0
2' 8.30 d (2.0) 114.3 8.26 d (2.0) 114.4 8.11 d (2.0) 117.8
3' 148.6 148.9 147.0
4' 149.5 150.0 148.5
5' 6.95 d (8.5) 115.8 6.96 d (8.5) 116.3 6.92 d (8.5) 116.0
6' 7.74 dd (8.5, 2.0) 123.5 7.73 dd (8.5, 2.0) 123.6 7.72 dd (8.5, 2.0) 122.6
OMe 4.03 s 56.9 4.00 s 57.0
Glca-1 5.51 d (7.5) 101.6 5.30 d (7.5) 104.5 5.13 d (7.5) 105.5
2 4.03 dd (9.0, 7.5) 76.0 3.87 dd (9.0, 7.5) 73.0 3.88 dd (9.0, 7.5) 73.0
3 3.56 t (9.0) 78.0 3.59 t (9.0) 77.0 3.60 t (9.0) 77.0
4 3.73 t (9.0) 71.2 3.75 t (9.0) 70.0 3.77 t (9.0) 70.0
5 3.74 m 75.0 3.60 m 75.0 3.61 m 75.0
6a 3.77 dd (12.0, 3.0) 68.6 3.83 dd (12.0, 3.0) 69.0 3.74 dd (12.0, 3.0) 68.0
6b 3.66 dd (12.0, 4.5) 3.73 dd (12.0, 4.5) 3.70 dd (12.0, 4.5)
Apib-1 5.46 d (2.0) 110.4
2 4.06 d (2.0) 77.0
3 80.4
4a 4.09 d (10.0) 75.6
4b 3.69 d (10.0)
5 3.68 br s 66.4
Xylc-1 4.24 d (7.5) 102.3 4.20 d (7.5) 103.0 4.12 d (7.5) 102.6
2 4.41 dd (9.0, 7.5) 75.0 4.44 dd (9.0, 7.5) 75.3 4.43 dd (9.0, 7.5) 74.6
3 3.10 t (9.0) 75.6 3.07 t (9.0) 75.5 3.04 t (9.0) 75.6
4 3.38 m 71.3 3.39 m 71.0 3.43 m 71.0
5a 3.83 dd (10.5, 2.0) 66.4 3.69 dd (10.5, 2.0) 65.5 3.73 dd (10.5, 2.0) 66.6
5b 3.59 dd (10.5, 5.0) 2.70 dd (10.5, 5.0) 2.84 dd (10.5, 5.0)
COCH3 171.0 172.0 172.0
COCH3 1.71 s 20.0 1.71 s 20.0 1.71 s 20.0
Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments.
a Glc = β-D-glucopyranose, b  =  Api β-D-apiofuranose, c  = Xyl  β-D-xylopyranose. 
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Table 4 IC50 (µM) of compounds 1 and 2 in different cancer cell lines.
compound HeLaa Jurkatb MCF7c
1 57 42 59
2 71 60 67
acervical carcinoma; bT-cell leukemia; cbreast carcinoma
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